Mayes, Patrick A.
GlaxoSmithKline (United States)
4 papers on CoChatORCID 0000-0001-9104-4161
Most cited papers
- Verified
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
Liu, L., Mayes, P. A., Eastman, S., Shi, H., Yadavilli, S., Zhang, T., Yang, J., Seestaller-Wehr, L., Zhang, S.-Y., Hopson, C., et al. (2015) · Clinical Cancer Research
Melanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers
Cited by 446
- Verified
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., et al. (2012) · Cancer Cell
Cell death mechanisms and regulationCancer, Hypoxia, and Metabolism
Cited by 375
- Verified
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
Cole, K. A., Huggins, J., Laquaglia, M., Hulderman, C. E., Russell, M. R., Bosse, K., Diskin, S. J., Attiyeh, E. F., Sennett, R., Norris, G., et al. (2011) · Proceedings of the National Academy of Sciences
Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases
Cited by 249
- Verified
Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1α
Qing, G., Skuli, N., Mayes, P. A., Pawel, B., Martinez, D., Maris, J. M., & Simon, M. C. (2010) · Cancer Research
Neuroblastoma Research and TreatmentsCancer, Hypoxia, and Metabolism
Cited by 157
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free